Impact of Hyper- and Hypo-Uricemia on Kidney Function

Area of Science:

• Nephrology
• Biochemistry
• Urology

Background:

• Uric acid (UA) plays a dual role, acting as a pro-inflammatory agent via monosodium urate (MSU) crystals and as a potent antioxidant.
• Abnormal uric acid levels (hyperuricemia and hypouricemia) stem from genetic factors and are linked to various kidney diseases, including gout nephropathy and renal stones.
• Renal hypouricemia (RHU) is characterized by impaired tubular reabsorption of UA, leading to increased urinary UA and potential kidney stone formation.

Purpose of the Study:

• To elucidate the complex relationship between uric acid levels and kidney function.
• To investigate the mechanisms by which hyperuricemia and hypouricemia contribute to kidney damage.
• To explore potential therapeutic strategies for protecting kidney function in conditions of abnormal uric acid levels.

Main Methods:

• Review of existing literature on uric acid's role in kidney diseases.
• Analysis of the association between uric acid levels, urinary UA concentration, and renal outcomes.
• Examination of the impact of uric acid on endothelial function and oxidative stress.

Main Results:

• Hyperuricemia is associated with gout nephropathy, renal arteriopathy, increased urinary albumin excretion, and impaired endothelial function.
• Renal hypouricemia (RHU) is linked to renal stones and tubular damage, potentially due to increased urinary UA precipitation.
• Both high and low uric acid levels can negatively impact kidney function, exhibiting a U-shaped association with organ damage.

Conclusions:

• Uric acid's role in kidney health is complex, with both excess and deficiency posing risks.
• Hyperuricemia management with urate-lowering agents is recommended for patients with kidney disease.
• For RHU patients, hydration, urinary alkalization, and potentially XOR inhibitors may help preserve kidney function.